1,739
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Intra-host emergence of an enterovirus A71 variant with enhanced PSGL1 usage and neurovirulence

, , , ORCID Icon, , , , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1076-1085 | Received 13 Feb 2019, Accepted 11 Jul 2019, Published online: 24 Jul 2019

References

  • Ooi MH, Wong SC, Lewthwaite P, et al. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9:1097–1105. DOI:10.1016/S1474-4422(10)70209-X.
  • Wong KT, Munisamy B, Ong KC, et al. The distribution of inflammation and virus in human Enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J Neuropathol Exp Neurol. 2008;67:162–169. DOI:10.1097/nen.0b013e318163a990.
  • Puenpa J, Mauleekoonphairoj J, Linsuwanon P, et al. Prevalence and characterization of enterovirus infections among pediatric patients with hand foot mouth disease, herpangina and influenza like illness in Thailand, 2012. PLoS One. 2014;9:e98888. DOI:10.1371/journal.pone.0098888.
  • Liu W, Wu S, Xiong Y, et al. Co-circulation and genomic recombination of coxsackievirus A16 and enterovirus 71 during a large outbreak of hand, foot, and mouth disease in Central China. PLoS One. 2014;9:e96051. DOI:10.1371/journal.pone.0096051.
  • Thoa LPK, Chiang P-S, Khanh TH, et al. Genetic and antigenic characterization of enterovirus 71 in Ho Chi Minh City, Vietnam, 2011. PLoS One. 2013;8:e69895. DOI:10.1371/journal.pone.0069895.
  • Akhmadishina LV, Eremeeva TP, Trotsenko OE, et al. Seroepidemiology and molecular epidemiology of enterovirus 71 in Russia. PLoS One. 2014;9:e97404. DOI:10.1371/journal.pone.0097404.
  • Fonseca MC, Sarmiento L, Resik S, et al. Coxsackievirus A6 and enterovirus 71 causing hand, foot and mouth disease in Cuba, 2011-2013. Arch Virol. 2014;159:2451–2455. DOI:10.1007/s00705-014-2071-x.
  • Van Der Sanden SMG, Sachs N, Koekkoek SM, et al. Enterovirus 71 infection of human airway organoids reveals VP1-145 as a viral infectivity determinant article. Emerg Microbes Infect. 2018;7:1–9. DOI:10.1038/s41426-018-0077-2.
  • Yi E-J, Shin Y-J, Kim J-H, et al. Enterovirus 71 infection and vaccines. Clin Exp Vaccine Res. 2017;6:4. DOI:10.7774/cevr.2017.6.1.4.
  • Tseligka ED, Sobo K, Stoppini L, et al. A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism. PLoS Pathog. 2018;14:e1007190. DOI:10.1371/journal.ppat.1007190.
  • Zhang Y, Cui W, Liu L, et al. Pathogenesis study of enterovirus 71 infection in rhesus monkeys. Lab Investig. 2011;91:1337–1350. DOI:10.1038/labinvest.2011.82.
  • Royston L, Tapparel C. Rhinoviruses and respiratory enteroviruses: not as simple as ABC. Viruses. 2016;8(1):16. DOI:10.3390/v8010016.
  • Solomon T, Lewthwaite P, Perara D, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10(11):778–790. doi: 10.1016/S1473-3099(10)70194-8
  • Wang S, Liu C-C, Tseng H-W, et al. Clinical Spectrum of enterovirus 71 infection in children in southern Taiwan, with an Emphasis on neurological complications. Clin Infect Dis. 2007;29:184–190. DOI:10.1086/520149.
  • Victorio CBL, Xu Y, Ng Q, et al. A clinically authentic mouse model of enterovirus 71 (EV-A71)-induced neurogenic pulmonary oedema. Sci Rep. 2016;6. DOI:10.1038/srep28876.
  • Huang C-C, Liu C-C, Chang Y-C, et al. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 2002;341:936–942. DOI:10.1056/nejm199909233411302.
  • Baggen J, Jan Thibaut H, Strating JRPM, et al. The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol. 2018;16(6):368–381. doi: 10.1038/s41579-018-0005-4
  • Nishimura Y, Lee H, Hafenstein S, et al. Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction. PLoS Pathog. 2013;9(7):e1003511. DOI:10.1371/journal.ppat.1003511.
  • Liu Y, Fu C, Wu S, et al. A novel finding for enterovirus virulence from the capsid protein VP1 of EV71 circulating in mainland China. Virus Genes. 2014;48:260–272. DOI:10.1007/s11262-014-1035-2.
  • Wang Y-F, Yu C-K. Animal models of enterovirus 71 infection: applications and limitations. J Biomed Sci. 2014;21:31. DOI:10.1186/1423-0127-21-31.
  • Marc T. Brain development and the immune system: an introduction to inflammatory and infectious diseases of the child’s brain. Handb Clin Neurol. 2013;112:1087–1089. doi: 10.1016/B978-0-444-52910-7.00026-X
  • Zaini Z, Phuektes P, McMinn P. Mouse adaptation of a sub-genogroup B5 strain of human enterovirus 71 is associated with a novel lysine to glutamic acid substitution at position 244 in protein VP1. Virus Res. 2012;167:86–96. DOI:10.1016/j.virusres.2012.04.009.
  • Khong WX, Yan B, Yeo H, et al. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J Virol. 2012;86:2121–2131. DOI:10.1128/JVI.06103-11.
  • Fujii K, Nagata N , Sato Y, et al. Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc Natl Acad Sci U S A. 2013;110:14753–14758. DOI:10.1073/pnas.1217563110.
  • Caine EA, Moncla LH, Ronderos MD, et al. A single mutation in the VP1 of enterovirus 71 is responsible for increased virulence and neurotropism in adult interferon-deficient mice. J Virol. 2016;90:8592–8604. DOI:10.1128/JVI.01370-16.
  • Pathinayake PS, Hsu ACY, Wark PAB. Innate immunity and immune evasion by enterovirus 71. Viruses. 2015;7:6613–6630. DOI:10.3390/v7122961.
  • Ida-Hosonuma M, Iwasaki T, Yoshikawa T, et al. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J Virol. 2005;79:4460–4469. DOI:10.1128/JVI.79.7.4460-4469.2005.
  • Chen C-S, Yao Y-C, Lin S-C, et al. Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. J Virol. 2007;81:8996–9003. DOI:10.1128/JVI.00236-07.
  • Koyuncu OO, Hogue IB, Enquist LW. Virus infections in the nervous system. Cell Host Microbe. 2013;13:379–393. DOI:10.1016/j.chom.2013.03.010.
  • Liu J, Dong W, Quan X, et al. Transgenic expression of human P-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice. Arch Virol. 2012;157:539–543. DOI:10.1007/s00705-011-1198-2.
  • Victorio CBL, Xu Y, Ng Q, et al. Phenotypic and genotypic characteristics of novel mouse cell line (NIH/3T3)-adapted human enterovirus 71 strains (EV71:TLLm and EV71:TLLmv). PLoS One. 2014;9:e92719. DOI:10.1371/journal.pone.0092719.
  • Jiao XY, Guo L, Huang DY, et al. Distribution of EV71 receptors SCARB2 and PSGL-1 in human tissues. Virus Res. 2014;190:40–52. DOI:10.1016/j.virusres.2014.05.007.
  • Chen P, Song Z, Qi Y, et al. Molecular determinants of enterovirus 71 viral entry: Cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J Biol Chem. 2012;287:6406–6420. DOI:10.1074/jbc.M111.301622.
  • Victorio CBL, Xu Y, Ng Q, et al. Cooperative effect of the VP1 amino acids 98E, 145A and 169F in the productive infection of mouse cell lines by enterovirus 71 (BS strain). Emerg Microbes Infect. 2016;5:1–14. DOI:10.1038/emi.2016.56.
  • Plevka P, Perera R, Yap ML, et al. Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc Natl Acad Sci. 2013;110:5463–5467. DOI:10.1073/pnas.1222379110.
  • Miyamura K, Nishimura Y, Abo M, et al. Adaptive mutations in the genomes of enterovirus 71 strains following infection of mouse cells expressing human P-selectin glycoprotein ligand-1. J Gen Virol. 2011;92:287–291. DOI:10.1099/vir.0.022418-0.
  • Nishimura Y, Wakita T, Shimizu H. Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection. PLoS Pathog. 2010;6(11):e1001174. DOI:10.1371/journal.ppat.1001174.
  • Zhou D, Zhao Y, Kotecha A, et al. Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2. Nat Microbiol. 2019;4:414–419. DOI:10.1038/s41564-018-0319-z.